Gardasil

Also found in: Wikipedia.

Gardasil

(gär′də-sĭl′)

A trademark for a recombinant vaccine administered intramuscularly to immunize against certain types of human papillomavirus that can cause genital warts and cervical, vulvar, vaginal, and anal cancer.

Gardasil

(găr′dă-sĭl)

Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine.

Mentioned in ?

References in periodicals archive ?

The American Cancer Society is the lead institution for promoting the Merck vaccine called Gardasil. Ms.

Keep parent-physician role in vaccines

Details of the ACIP recommendations for GARDASIL 9 will be available from the CDC.

CDC Advisory Committee on Immunization Practices Votes to Provisionally Recommend Shared Clinical Decision-Making for Vaccination of Adults Ages 27-45 with GARDASIL9 and Harmonization of Catch-up Vaccination for Males and Females Through Age 26

In September 2005, seven months before FDA approval of its Gardasil vaccine, Merck commenced a direct-to-consumer marketing campaign that connected the human papilloma virus (HPV) to cervical cancer.

When Marketing Trumps Science

The US Food and Drug Administration (FDA) recently extended the approval for Gardasil 9 (to prevent HPV-associated cancers, cancer precursors, and genital lesions) to men and women aged 27 to 45.

The HPV vaccine is now recommended for adults aged 27-45: Counseling implications: Can we improve human papillomavirus (HPV) vaccination rates among boys and girls so "catch-up" vaccinations in adults are unnecessary?

HPV, Gardasil and Gardasil 9_Vaccines Training.pdf.

Debunking the myths about HPV

The vaccine (Gardasil 9) was previously approved for those aged 9-26 years.

FDA expands approval of 9-valent HPV vaccine

Food and Drug Administration has expanded coverage of the HPV vaccine Gardasil 9 to include patients between the ages of 27 and 45.

Local health experts tout expanded use of HPV vaccine

M2 EQUITYBITES-October 9, 2018-Merck receives US FDA approval to expand Gardasil 9 use

Merck receives US FDA approval to expand Gardasil 9 use

Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release.

FDA Approves HPV Vaccine for People Through Age 45; Updated vaccine designed to prevent cancers and disease caused by nine HPV types

Global Banking News-October 8, 2018-The US Food and Drug Administration approves the expanded use of Gardasil 9

The US Food and Drug Administration approves the expanded use of Gardasil 9

Food and Drug Administration approved Gardasil for use in girls and young women, ages 9-26, to prevent certain cancers and diseases caused by four HPV types.